Gene · 4689
Papers1,992
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,992
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis. | Front Mol Biosci | 2023 | 37091868 | PubTator, text mining | PubMed |
| Glutathione peroxidase 3 is a novel clinical diagnostic biomarker and potential therapeutic target for neutrophils in rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37087463 | PubTator, text mining | PubMed |
| Autophagy in protists and their hosts: When, how and why? | Autophagy Rep | 2023 | 37064813 | PubTator, text mining | PubMed |
| HMGB1, angel or devil, in ischemic stroke. | Brain Behav | 2023 | 37062906 | PubTator, text mining | PubMed |
| Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. | Blood Adv | 2023 | 37058477 | PubTator, text mining | PubMed |
| RAGE signaling regulates the progression of diabetic complications. | Front Pharmacol | 2023 | 37007029 | PubTator, text mining | PubMed |
| Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia. | Front Oncol | 2023 | 36998465 | PubTator, text mining | PubMed |
| Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment. | Int J Nanomedicine | 2023 | 36992821 | PubTator, text mining | PubMed |
| The EGFR phosphatase RPTPγ is a redox-regulated suppressor of promigratory signaling. | EMBO J | 2023 | 36988334 | PubTator, text mining | PubMed |
| Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases. | Pathogens | 2023 | 36986378 | PubTator, text mining | PubMed |
| Critical Response to Article "Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis" [Letter]. | Drug Des Devel Ther | 2023 | 36969706 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from CD4+ T cells carry DGKK to promote sepsis-induced lung injury by regulating oxidative stress and inflammation. | Cell Mol Biol Lett | 2023 | 36959535 | PubTator, text mining | PubMed |
| Accurate bundle matching and generation via multitask learning with partially shared parameters. | PLoS One | 2023 | 36928193 | PubTator, text mining | PubMed |
| Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. | Cell Commun Signal | 2023 | 36918950 | PubTator, text mining | PubMed |
| Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis. | Drug Des Devel Ther | 2023 | 36915642 | PubTator, text mining | PubMed |
| The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling. | Molecules | 2023 | 36903347 | PubTator, text mining | PubMed |
| Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36902173 | PubTator, text mining | PubMed |
| Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations. | Cancer Cell Int | 2023 | 36899388 | PubTator, text mining | PubMed |
| Spontaneous NETosis in diabetes: A role of hyperglycemia mediated ROS and autophagy. | Front Med (Lausanne) | 2023 | 36895726 | PubTator, text mining | PubMed |
| Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis. | J Clin Immunol | 2023 | 36892687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4689/papers?page=9